GE HealthCare Technologies Inc.
GEHC Healthcare Medical Devices
GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024.
- Revenue
- +7.19%
- EPS
- +40.6%
- Free cash flow
- +64.2%
- Total debt
- −1.90%
Quarter to September 2026, against a year earlier
Follow GEHC
Alert me
GE HealthCare Technologies Inc. (GEHC) Gross margin
GE HealthCare Technologies Inc.'s gross margin over the twelve months to 30 September 2026 was 40.0%, down 0.0 percentage points from fiscal 2025 (40.0%). Over the past ten years it has ranged from 39.1% (fiscal 2022) to 41.7% (fiscal 2024); the current reading is higher than 57% of that period. That is below the Medical Devices industry median of 57.8% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 40.0% | (1.72) |
| FY2024 | 41.7% | 1.19 |
| FY2023 | 40.5% | 1.38 |
| FY2022 | 39.1% | (1.66) |
| FY2021 | 40.8% | 1.37 |
| FY2020 | 39.4% | 0.06 |
| FY2019 | 39.4% | — |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 40.3% | (0.83) |
| Jun 2026 | 41.2% | 2.64 |
| Mar 2026 | 38.5% | (1.17) |
| Dec 2025 | 39.7% | 1.03 |
| 15 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| GKOS Glaukos Corporation compare | 81.1% |
| EW Edwards Lifesciences Corporation compare | 78.0% |
| SNN Smith & Nephew SNATS, Inc. compare | 70.5% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 69.7% |
| BSX Boston Scientific Corporation compare | 69.1% |
| DXCM DexCom, Inc. compare | 63.4% |
| PHG Koninklijke Philips N.V. compare | 46.4% |
| STE STERIS plc compare | 44.6% |
| GEHC GE HealthCare Technologies Inc. | 40.0% |
| Medical Devices industry median | 57.8% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on GEHC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement